Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-16 9:43 pm Purchase | 2024-08-29 | 13D | Galecto, Inc. GLTO | Novo Holdings A/S | 99,913 7.600% | 1 (+0.00%) | Filing History |
| 2024-11-22 9:11 pm Sale | 2024-11-20 | 13G | Exscientia plc EXAI | Novo Holdings A/S | 0 0.000% | -13,086,600 (Position Closed) | Filing History |
| 2024-09-23 9:20 pm Sale | 2024-09-19 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 5,549,900 5.900% | -794,530 (-12.52%) | Filing History |
| 2024-09-17 9:01 pm Sale | 2024-09-13 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 5,823,584 8.500% | -1,075,000 (-15.58%) | Filing History |
| 2024-06-24 9:06 pm Unchanged | 2024-06-20 | 13D | Galecto, Inc. GLTO | Novo Holdings A/S | 99,912 9.200% | 0 (Unchanged) | Filing History |
| 2024-05-14 9:35 pm Sale | 2024-05-10 | 13G | IO Biotech, Inc. IOBT | Novo Holdings A/S | 6,898,584 10.100% | -658,809 (-8.72%) | Filing History |
| 2024-03-28 9:15 pm Sale | 2024-03-26 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 1,656,000 3.900% | -1,100,000 (-39.91%) | Filing History |
| 2024-03-25 9:48 pm Sale | 2024-03-21 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 2,756,000 6.400% | -1,915,021 (-41.00%) | Filing History |
| 2024-03-20 9:31 pm Sale | 2024-03-18 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 4,671,021 10.900% | -1,794,999 (-27.76%) | Filing History |
| 2024-03-18 9:16 pm Sale | 2024-03-14 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 6,466,020 15.100% | -1,912,316 (-22.82%) | Filing History |
| 2024-03-07 7:09 pm Sale | 2024-03-05 | 13D | LAVA Therapeutics N.V. LVTX | Novo Holdings A/S | 0 0.000% | -1,878,194 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Evotec SE EVO | Novo Holdings A/S | 14,931,858 8.400% | -2,512,949 (-14.41%) | Filing History |
| 2024-02-13 9:34 pm Sale | 2024-02-09 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 7,557,393 11.100% | -658,809 (-8.02%) | Filing History |
| 2024-01-25 4:26 pm Purchase | 2024-01-23 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 6,344,430 7.400% | 272,727 (+4.49%) | Filing History |
| 2024-01-02 4:29 pm Sale | 2023-12-27 | 13G | Rallybio Corporation RLYB | Novo Holdings A/S | 1,767,861 4.700% | -528,146 (-23.00%) | Filing History |
| 2023-12-15 4:55 pm Sale | 2023-12-14 | 13D | Reneo Pharmaceuticals, Inc. RPHM | Novo Holdings A/S | 0 0.000% | -343,038 (Position Closed) | Filing History |
| 2023-12-15 4:51 pm Purchase | 2023-12-11 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Novo Holdings A/S | 1,307,829 4.900% | 13,776 (+1.06%) | Filing History |
| 2023-11-24 4:33 pm Purchase | 2023-11-15 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Novo Holdings A/S | 1,294,053 5.100% | 1,294,053 (New Position) | Filing History |
| 2023-11-09 4:37 pm Sale | 2023-11-03 | 13D | LAVA Therapeutics N.V. LVTX | Novo Holdings A/S | 1,878,194 7.100% | -521,806 (-21.74%) | Filing History |
| 2023-08-11 4:40 pm Purchase | 2023-08-09 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 8,216,202 12.000% | 4,938,270 (+150.65%) | Filing History |